FirstWord report gives insight on biosimilars market
"Biosimilars: U.S. Payer Perspectives," a report by FirstWord that provides details on the U.S. biologics market and gives insights from 12 United States payers from a variety of different organizations, projects spending on biologics will reach $100 billion in the U.S. over the next few years. Read More »